Canadian bronchiectasis and NTM patient registry study
Part of Lungs & breathing clinical trials.
This study will build a Canadian registry for people with bronchiectasis (not from cystic fibrosis) and NTM infections. The goal is to track health outcomes over time to improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You have been diagnosed with bronchiectasis that is not due to cystic fibrosis
- You have, or have had, a nontuberculous mycobacteria (NTM) infection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the community of tiny organisms in the lungs (the lung microbiome) in people with bronchiectasis caused by NTM (non-tuberculous mycobacteria). It compares people with positive NTM cultures to people without, to better understand what’s going on in the lungs and why symptoms may differ.
This study compares the health of people with NTM lung disease (not on antibiotics) to people with bronchiectasis (who have never had NTM infection). It aims to understand how these conditions affect daily life.
This study helps doctors identify different types of bronchiectasis (a lung disease where airways are permanently widened and damaged) to better understand how the disease develops and progresses. By following patients over time and collecting medical information, researchers hope to create a system that predicts which patients will worsen and need different treatments.
This study keeps a real-world record of people in Korea with a lung infection caused by specific non-tuberculous mycobacteria (not tuberculosis). It may help researchers better understand these infections and treatment patterns by tracking patients as they start new therapy.
This study helps doctors understand how severe your bronchiectasis is and predict when you might have flare-ups. You'll have routine tests over 12 months to help researchers learn more about this condition and improve future care.
This study looks at how bacteria live in the lungs of people with bronchiectasis and how they may adapt over time. It may help researchers understand why infections keep coming back and how to better manage chronic lung colonization.
Hear when a new Bronchiectasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.